Cover Image

Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway

Abstract Dosage optimization to maximize efficacy and minimize toxicity is a potential issue when administering radiotherapy (RT) in combination with immune checkpoint blockade (ICB) or inhibitors of the DNA Damage Response Pathway (DDRi) in the clinic. Preclinical models and mathematical modeling c...

Full description

Saved in:

Bibliographic Details
Main Authors:	David Hodson (Author), Hitesh Mistry (Author), Sofia Guzzetti (Author), Michael Davies (Author), Anna Staniszewska (Author), Paul Farrington (Author), Elaine Cadogan (Author), James Yates (Author), Leon Aarons (Author), Kayode Ogungbenro (Author)
Format:	Book
Published:	Wiley, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Radiotherapy for Melanoma: More than DNA Damage
by: Susanne J. Rogers, et al.
Published: (2019)

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
by: Mathilde Bausart, et al.
Published: (2022)

Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
by: Melissa Sarver, et al.
Published: (2022)

Investigation of simplified physiologically‐based pharmacokinetic models in rat and human
by: Estelle Yau, et al.
Published: (2023)

A "middle‐out approach" for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models
by: Estelle Yau, et al.
Published: (2023)

Differential Effect of Schisandrin B Stereoisomers on ATR-Mediated DNA Damage Checkpoint Signaling
by: Naoto Tatewaki, et al.
Published: (2013)

Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer
by: Xing Bian, et al.
Published: (2023)

Severe recalcitrant cutaneous eruption with dual immune checkpoint blockade
by: Sakeena Fatima, BA, et al.
Published: (2018)

Immune checkpoint blockade therapy in head and neck cancer: a review
by: Shajedul Islam, et al.
Published: (2018)

Tumor lysis syndrome and collateral immune activation in dual checkpoint blockade
by: Risa Konishi, et al.
Published: (2021)

Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis
by: Yantao Xu, et al.
Published: (2022)

Blockade of neutrophil recruitment to tumor sites based on sialic acid-modified nanoplatforms enhances the efficacy of checkpoint blockade immunotherapy
by: Meng Chen, et al.
Published: (2023)

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade
by: Damian J. Ralser, et al.
Published: (2023)

Scarring Alopecia Under Immune Checkpoint Blockade: a Report of Three Cases
by: Sonja Braasch, et al.
Published: (2022)

Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8 T-cell activation and exhaustion
by: José Belizário, et al.
Published: (2020)

Luteolin Alleviates Cadmium-Induced Kidney Injury by Inhibiting Oxidative DNA Damage and Repairing Autophagic Flux Blockade in Chickens
by: Kanglei Zhang, et al.
Published: (2024)

Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology
by: Benjamin A Babalola, et al.
Published: (2021)

Combinatorial Approaches to Enhance Anti-Tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
Published: (2019)

Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator
by: Qingqing Xiao, et al.
Published: (2023)

Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
by: Yuxuan Liu, et al.
Published: (2024)

Biomarkers of Brain Damage Induced by Radiotherapy
by: Nahida Sultana, et al.
Published: (2020)

Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors
by: Qiuyu Wu, et al.
Published: (2023)

Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies
by: Ai Tsuji, et al.
Published: (2023)

Computational Modeling of Signaling Pathways Mediating Cell Cycle Checkpoint Control and Apoptotic Responses to Ionizing Radiation-Induced DNA Damage
by: Yuchao Zhao, et al.
Published: (2012)

On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition
by: Xiaoqing Liu, et al.
Published: (2023)

Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy
by: Yongrong Yao, et al.
Published: (2022)

Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy
by: Yunzhu Lin, et al.
Published: (2024)

Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
by: Jiulong Zhang, et al.
Published: (2022)

Skipping a pillar does not make for strong foundations: Pharmacokinetic‐pharmacodynamic reasoning behind the shape of dose-response relationships in oncology
by: James W. T. Yates, et al.
Published: (2023)

27 HIV-associated gastrointestinal microbial dysbiosis influences the efficacy of anti-HIV immunity by immune checkpoint blockade
by: I.N. SahBandar, et al.
Published: (2017)

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer
by: Mengjie Wang, et al.
Published: (2022)

Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
by: Jing Yu, et al.
Published: (2022)

In-situ formed thermosensitive hydrogel amplifies statin-mediated immune checkpoint blockade for coordinated tumor chemo-immunotherapy
by: Zefan Liu, et al.
Published: (2023)

Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects
by: James Brown, et al.
Published: (2022)

Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer
by: Jiaojie Wei, et al.
Published: (2019)

Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy
by: Yujeong Moon, et al.
Published: (2024)

Pheophorbide A-Mediated Photodynamic Therapy Potentiates Checkpoint Blockade Therapy of Tumor with Low PD-L1 Expression
by: Qinli Tong, et al.
Published: (2022)

Dose-Volume Constraints Parameters for Lung Tissue in Thoracic Radiotherapy Following Immune Checkpoint Inhibitor Treatment
by: Wang K, et al.
Published: (2024)

The damage and remineralization strategies of dental hard tissues following radiotherapy
by: Lin Yao, et al.
Published: (2024)

Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade
by: David M. Miller, MD, PhD, et al.
Published: (2017)